Table 2.
Biochemical and Paraclinical Parameters of Patients with RA and CS
|
CS (n = 270) Median (P25−P75) |
RA (n = 216) Median (P25−P75) |
p‐value | |
|---|---|---|---|
| Glucose (mg/dl) | 93 (88−101) | 95 (89−100) | 0.2539 |
| Triglycerides (mg/dl) | 109 (78−164) | 99 (78−135) | 0.1434 |
| Total cholesterol (mg/dl) | 183 (150−213) | 168 (143−196) | 0.0045 |
| HDL‐C (mg/dl) | 42 (35−48) | 43 (37−53) | 0.0681 |
| LDL‐C (mg/dl) | 116 (90−134) | 102 (82−121) | 0.0006 |
| VLDL‐C (mg/dl) | 22 (16−33) | 20 (16−27) | 0.2975 |
| CRI‐I | 4.27 (3.5−5) | 3.89 (3.2−4.5) | 0.0002 |
| CRI‐II | 2.65 (2.1−3.3) | 2.3 (1.8–2.8) | <0.0001 |
Data expressed as median and interquartile ranges (25th percentile [P25] and 75th percentile [P75], Mann‐Whitney test. Bold letters indicate statistically significant results.
Abbreviations: CRI‐I, Castelli's Risk Index I; CRI‐II, Castelli's Risk Index II; HDL‐C, high‐density lipoprotein cholesterol; LDL‐C, low‐density lipoprotein cholesterol; milligrams (mg), deciliters (dl); VLDL‐C, very‐low‐density lipoprotein cholesterol.